Synthesis of IFN-gamma by CD8(+) T Cells is Preserved in HIV-infected Women with HPV-related Cervical Squamous Intraepithelial Lesions
Overview
Affiliations
Objective: The aim of this study was to investigate whether coinfection with HIV affects the synthesis of Th1 and Th2 cytokines by peripheral blood T cells of women infected with human papillomavirus (HPV).
Methods: Cervical swabs and peripheral blood were obtained from women referred for colposcopy. HPV DNA by Digene's hybrid capture assay, HIV RNA by Roche's Amplicor assay, and cytokine synthesis of T-cell subsets by flow cytometry were assessed. HPV-associated cervical and HIV-associated immune deficiency diseases were staged using the Bethesda System and the Centers for Disease Control criteria, respectively.
Results: Patients with HIV and/or HPV infections had lower percentages of IL-2(+) and higher percentages of IL-10(+) T cells than healthy women. Furthermore, women with both virus infections (HIV(+)/HPV(+)) had significantly fewer IL-2(+) CD4(+), IFN-gamma(+) CD4(+), and TNF-alpha(+) CD4(+) T cells than women with HPV infection alone (HPV(+)). Whereas HIV(+) and healthy women had similar numbers of IFN-gamma(+) CD8(+) T cells, HPV(+) women had significantly fewer IFN-gamma(+) CD8(+) T cells than healthy women.
Conclusion: HIV infection adversely affects the synthesis of Th1 cytokines by CD4(+), but not IFN-gamma synthesis by CD8(+) T cells of women with active HPV infection. The increase in IFNgamma(+) CD8(+) T cells, a phenotype consistent with cytotoxic T lymphocytes, may account for the stable HIV disease of the women studied. However, the increase in IFN-gamma(+) CD8(+) T cells is less likely to be HPV-specific as there was a higher incidence of HPV-related cervical SIL in HIV(+)/HPV(+) women compared with HPV(+) women.
Onohuean H, Aigbogun Jr E, Igere B Global Health. 2022; 18(1):36.
PMID: 35331267 PMC: 8943940. DOI: 10.1186/s12992-022-00812-w.
Impact of Helminth Infections on Female Reproductive Health and Associated Diseases.
Chetty A, Omondi M, Butters C, Smith K, Katawa G, Ritter M Front Immunol. 2020; 11:577516.
PMID: 33329545 PMC: 7719634. DOI: 10.3389/fimmu.2020.577516.
Ying Z, Li X, Dang H, Yin N, Gao C J Clin Lab Anal. 2019; 34(3):e23101.
PMID: 31785031 PMC: 7083446. DOI: 10.1002/jcla.23101.
Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System.
Zhou C, Tuong Z, Frazer I Front Oncol. 2019; 9:682.
PMID: 31428574 PMC: 6688195. DOI: 10.3389/fonc.2019.00682.
Lee B, Follen M, Shen D, Malpica A, Adler-Storthz K, Shearer W Clin Diagn Lab Immunol. 2004; 11(2):239-44.
PMID: 15013969 PMC: 371191. DOI: 10.1128/cdli.11.2.239-244.2004.